School of Medicine
Showing 1-10 of 45 Results
-
Mark A. Cappelli
Professor of Mechanical Engineering
BioProfessor Cappelli received his B.Sc. degree in Physics (McGill, 1980), and M.A.Sc and Ph.D. degrees in Aerospace Sciences (Toronto, 1983, 1987). He joined Stanford University in 1987 and is currently a Professor in the Department of Mechanical Engineering and Co-Director of the Engineering Physics Program. He carries out research in applied plasma physics with applications to a broad range of fields, including space propulsion, aerodynamics, medicine, materials synthesis, and fusion.
-
Ian Carroll, MD, MS
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
Current Research and Scholarly InterestsWe are committed to promoting an understanding of cerebrospinal fluid (CSF) leaks, and ensuring that all patients who are suffering from cerebrospinal fluid leaks receive appropriate diagnosis and treatment of this devastating, chronic, and fixable condition. We believe this can be best accomplished in a multidisciplinary setting involving expertise in radiology, neurology, and interventional pain medicine.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Alma-Martina Cepika
Assistant Professor of Surgery (General Surgery)
BioDr. Cepika is an immunologist with an extensive background in human immunology, genomics, and translational research. Her goal is to understand the mechanisms governing immune tolerance, and leverage this knowledge towards developing new therapies.
Dr. Cepika received her MD degree and a PhD in Immunology from the University of Zagreb School of Medicine in Croatia. There, she focused on the immunomonitoring of patients with lupus, identifying how circulating DNA levels changed with therapy. For her post-doctoral fellowship, she joined the lab of Dr. Virginia Pascual at the Baylor Institute for Immunology Research in Dallas, Texas. There, Dr. Cepika developed a multi-pronged in vitro stimulation assay, called the Tollgene assay, to evaluate the phenotype and function of blood leukocytes in patients with systemic juvenile idiopathic arthritis (sJIA). In combination with integrated bioinformatics analysis, this approach identified that sJIA patients have hyper-reactive monocytes, which primarily differentiate into macrophages rather than dendritic cells due to low expression of aryl hydrocarbon receptor.
As an Instructor in the Department of Pediatrics at Stanford, Dr. Cepika worked with Dr. Maria Grazia Roncarolo to investigate the biology and clinical applications of human inducible regulatory T cells (Tregs) called type 1 regulatory T (Tr1) cells. As well, she has spearheaded the efforts to understand the resistance of human leukemia cells to T cell killing.
Dr. Cepika's laboratory in the Department of Surgery will continue exploring the pathogenesis of human autoinflammatory conditions such as inflammatory bowel disease (IBD), the biology of human Tregs in the tumor microenvironment, and the role Tregs play in resistance to cancer immunotherapy. -
Anne Lynn S. Chang, MD
Professor of Dermatology
On Leave from 10/01/2025 To 11/30/2025Current Research and Scholarly InterestsMy two main research interests are:
1) To better understand and treat patients with aggressive basal and squamous cell carcinomas
2) To better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients, particularly skin cancer and rosacea -
Howard Y. Chang, MD, PhD
Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
On Leave from 12/16/2024 To 12/15/2026Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.
